• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

AcouSort

3.70 SEK

-5.85 %

Less than 1K followers

ACOU

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-5.85 %
-20.26 %
+21.31 %
+13.85 %
+30.74 %
+19.74 %
-76.99 %
-84.03 %
-53.11 %

AcouSort operates in the medical technology sector. The company has a developed platform technology focused on acoustophoresis, which uses ultrasound to separate and analyze the compositions of biological cells. The technology is mainly used in the analysis of cancer cases and sepsis (blood poisoning). A large part of the research is carried out in collaboration with other players in Life Science. The company was established in 2010 and has its headquarters in Lund.

Read more
Market cap
78.31M SEK
Turnover
41.86K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
26.8.
2026

Interim report Q2'26

25.11.
2026

Interim report Q3'26

24.2.
2027

Annual report '26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Press release29.06.2026 klo 10.00

AcouSort invited to key marketing and partnering events in Japan

AcouSort
Press release03.06.2026 klo 14.00

AcouSort receives an order for AcouWash from a global leader in veterinary diagnostics

AcouSort
Press release01.06.2026 klo 12.00

AcouSort to present and exhibit at the CYTO conference in West Palm Beach in June

AcouSort

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Press release28.05.2026 klo 19.37

Redeye: AcouSort (Q1 Review): Reduced financing concerns and further validation points

AcouSort
Regulatory press release27.05.2026 klo 08.00

AcouSort AB - Interim Report for the period January - March 2026

AcouSort
Regulatory press release20.05.2026 klo 15.30

AcouSort AB - Annual report 2025

AcouSort
Press release16.04.2026 klo 12.30

AcouSort sell an AcouTrap system to The Hebrew University of Jerusalem.

AcouSort
Press release16.03.2026 klo 09.30

AcouSort’s technology exhibited together with Moeller Medical’s system at Analytica

AcouSort
Regulatory press release10.03.2026 klo 18.30

AcouSort receives prepayment of royalties

AcouSort
Press release27.02.2026 klo 15.26

Redeye: AcouSort (Q4 review): Eventful year ahead

AcouSort
Regulatory press release25.02.2026 klo 07.00

Year end report for AcouSort AB 1 January – 31 December 2025

AcouSort
Press release23.01.2026 klo 12.50

AcouSort initiates new collaboration with global manufacturer

AcouSort
Press release29.12.2025 klo 11.00

AcouSort signs three more AcouWash system contracts

AcouSort
Press release19.12.2025 klo 11.40

AcouSort and MFX enter a collaboration to streamline future cell therapy manufacturing

AcouSort
Regulatory press release15.12.2025 klo 09.15

Stefan Blomsterberg elected new Chairman of the Board of AcouSort

AcouSort
Press release27.11.2025 klo 15.06

Redeye: AcouSort (Q3 review) - New collaboration alongside progress in existing one

AcouSort
Regulatory press release26.11.2025 klo 07.55

AcouSort AB - Interim Report for the period January - September 2025

AcouSort
Press release19.11.2025 klo 11.45

AcouSort and Danish SeeQ Diagnostics sign technology evaluation agreement

AcouSort
Press release22.09.2025 klo 11.40

AcouSort receives new order boosting Central European collaboration

AcouSort
Press release17.09.2025 klo 14.30

AcouSort to present at Redeye’s theme event Tools and Supplies in Life Science 2025

AcouSort